Cytomegalovirus (CMV) Antibodies Panel (IGG IGM)

Cytomegalovirus (CMV) is a common virus that usually causes mild or no symptoms. In some cases, mild illness may present with nonspecific symptoms like  sore throat, fever, tiredness, and swollen glands. Occasionally, otherwise healthy individuals may experience flu-like symptoms such as  extreme fatigue, fever, chills, body aches, or headaches, usually resolving within a few weeks. Many individuals may not be aware of their CMV infection as it typically does not cause problems in healthy individuals.

CMV infection can pose serious risks to certain populations, such as pregnant women and individuals with weak immune systems. Once infected, the body retains the virus for life without causing any symptoms. After the initial “primary” infection resolves, CMV becomes dormant or latent. However, if your immune system is significantly weakened, the virus can become active again (reactivate) and cause illness.

The Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) measures two types of antibodies: Immunoglobulin G (IgG) and Immunoglobulin M (IgM) which are produced as an immune response against CMV. Typically, IgM antibodies are the first responders, indicating recent CMV infection. However, IgM antibodies can also appear in cases of secondary (reactivated) CMV infection. On the other hand, IgG antibodies are produced several weeks after the initial CMV infection, indicating a past infection.  

This panel is typically advised during pregnancy, especially if there are concerns about congenital abnormalities, unexplained jaundice or anemia in a newborn, or if an infant has seizures or developmental problems related to CMV. Additionally, It is done as a part of the TORCH (Toxoplasmosis(T), Rubella(R), Cytomegalovirus(C), and Herpes Simplex (H) virus infections) panel, a group of tests that screen for several infections that can potentially affect a growing baby during pregnancy. Moreover, this test is recommended for individuals undergoing organ transplants, those with weak immune systems, and when symptoms indicating a potential CMV infection are observed. 

Currently, there is no approved vaccine for CMV infection. Early detection and effective treatment are crucial to managing the condition and preventing serious complications in those most at risk of CMV infection.  

No special preparation is required before undergoing a Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) test. However, it is important to inform your doctor about any medications, supplements or medical conditions before the test as these factors may potentially influence the test results.

Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation; therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results.The insights from this test helps the doctor tailor appropriate treatment plan.